NeuroPace to Participate in Upcoming Conferences
MOUNTAIN VIEW, Calif., Aug. 23, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE) announced participation in three significant healthcare conferences.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
MOUNTAIN VIEW, Calif., Aug. 23, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE) announced participation in three significant healthcare conferences. The schedule includes:
- Wells Fargo Virtual Healthcare Conference on September 10, 2021, at 9:20 a.m. ET.
- Morgan Stanley Global Healthcare Conference on September 14, 2021, at 3:30 p.m. ET.
- Baird Global Healthcare Conference on September 15, 2021, at 2:35 p.m. ET.
Live audio will be available on the company’s website, with archives accessible for at least 90 days post-event.
Details
News Market Reaction – NPCE
The recorded move for NPCE in the trading session of this news was +0.44%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MOUNTAIN VIEW, Calif., Aug. 23, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy, today reported that the company will be participating in three upcoming conferences.
- 2021 Wells Fargo Virtual Healthcare Conference
Fireside Chat on Friday, September 10, 2021, at 9:20 a.m. Eastern Time / 6:20 a.m. Pacific Time.
- 19th Annual Morgan Stanley Global Healthcare Conference
Fireside Chat on Tuesday, September 14, 2021, at 3:30 p.m. Eastern Time / 12:30 p.m. Pacific Time.
- 2021 Baird Global Healthcare Conference
Presentation on Wednesday, September 15, 2021, at 2:35 pm Eastern Time / 11:35 am Pacific Time.
Live audio of the webcasts of the presentations will be available on the “Investors” section of the company’s website at: https://www.neuropace.com. The webcasts will be archived and available for replay for at least 90 days after the event.
About NeuroPace, Inc.
Based in Mountain View, Calif., NeuroPace is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is the first and only commercially available, brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients suffering from drug-resistant epilepsy and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders.
Investor Contact:
Gilmartin Group
Matt Bacso, CFA
investors@neuropace.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.